UK's Tate & Lyle H1 revenue rises, maintains 2027 forecast

By Reuters News


Overview

  • UK food ingredients maker's preliminary H1 revenue was GBP 1.04 bln

  • Adjusted pretax profit for preliminary H1 was GBP 102 mln

  • Company raised interim dividend to 6.8p from 6.6p per share


Outlook

  • Company maintains outlook for modest constant-currency revenue growth, weighted to H2

  • Group expects broadly flat EBITDA before US$20 mln bio-gums capacity consolidation impactResults Driver

  • PRICING-LED VOLUME/MIX – Strategic 2026 customer-contract pricing actions delivered 3% volume/mix growth, partly offset by a 2% price decline

  • US TARIFFS AND EUROPEAN SWEETENERS – US tariff reimbursements and declining European bulk sweeteners and co-products weighed on revenue

  • COST INFLATION AND INVESTMENT – Adjusted EBITDA fell as pricing actions, capability and IT spending, and EMEA inflation outweighed volume growth, synergies and productivity savings


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

GBP 1.04 bln

H1 Adjusted Pretax Profit

GBP 102 mln

H1 Dividend

GBP 0.07


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the food processing peer group is "buy."

  • Wall Street's median 12-month price target for Tate & Lyle PLC is GBp595.00, about 5.3% above its November 4 closing price of GBp565.00

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago


Reuters Recommended Reads

  • Nov 3 - UK's Associated British Foods FY revenue, profit beat estimates

  • Nov 4 - UK's Nomad Foods Q3 revenue rises 2.3%, guidance reiterated

  • Nov 3 - Primark-owner AB Foods forecasts further profit decline as sugar losses deepen


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.